Neoptosol
نيوبتوسول
Synergistic dual aminoglycoside oral solution. Each 1 ml contains Streptomycin sulfate 70 mg and Neomycin sulfate 70 mg. Indicated for the treatment of enteric colibacillosis in neonatal lambs caused by susceptible E. coli strains.
Dosage Form
N/A
Product Type
Pharmaceutical
Manufacturer
Package
N/A
Dosages
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Sheep | 1 ml of Neoptosol / 5 kg b.wt. in drinking water or milk twice daily for 3 consecutive days | oral | 3 days |
Withdrawal Periods
No withdrawal information available.
Indications
-
Treatment of neomycin and streptomycin sensitive enteric infections (colibacillosis / white scours) in neonatal lambs caused by Escherichia coli.
علاج الالتهابات المعوية الحساسة للنيومايسين والستربتومايسين (داء العصيات القولونية / إسهال الحملان الأبيض) في الحملان حديثي الولادة الناتجة عن الإشريكية القولونية.
Contraindications
No contraindications information available.
Precautions
No precautions information available.
Side Effects
No side effects information available.
Images
Documents
No documents available.
Active Ingredients
-
Streptomycin
70 mg/ml
-
Neomycin
70 mg/ml
Diseases
No diseases linked.
Related Products
No data available
Information has not been added yet.
Related Products By Active Ingredient
Companies
-
ATCO Pharma for Pharmaceutical Industries
Manufacturer
Alternatives
No alternatives available.